| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041864 Method for treatment of tumors using photodynamic therapy |
| 04/11/2002 | US20020041846 Metal complexes for use in medical and therapeutic applications |
| 04/11/2002 | DE10100586C1 Inhibiting gene expression in cells, useful for e.g. treating tumors, by introducing double-stranded complementary oligoRNA having unpaired terminal bases |
| 04/11/2002 | DE10048840A1 Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren Use of lipopeptides or lipoproteins in the treatment of lung infections and tumors |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2435976A1 Apoptosis inducers, caspase cascade activators and anticancer agents |
| 04/11/2002 | CA2426621A1 Drug resistance-associated gene and use thereof |
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2425281A1 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425264A1 Tumor proliferation inhibitors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424567A1 Method to alter sugar moieties |
| 04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424285A1 Use of lipopeptides or lipoproteins for the treatment of lung infections and lung tumours |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2424117A1 Phosphoric acid salt of an integrin receptor antagonist |
| 04/11/2002 | CA2424116A1 Antitumor therapy comprising distamycin derivatives |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/11/2002 | CA2421417A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
| 04/10/2002 | EP1195378A1 Pyridotriazines and pyridopyridazines |
| 04/10/2002 | EP1195159A1 Therapeutic combination of ascorbate with lysine or arginine for prevention and treatment of cancer |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194575A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/10/2002 | EP1194573A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194556A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194549A2 Human genes and gene expression products |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194545A2 Secreted polypeptides and corresponding polynucleotides |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194451A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194425A1 Substituted benzimidazole |
| 04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194165A1 Tagged epitope protein transposable element |
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1194129A1 Self-emulsifying systems containing anticancer medicament |
| 04/10/2002 | EP1194044A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP1021178A4 Selenophene anti-tumor agents |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0927150B1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 04/10/2002 | EP0813535B1 Hexacyclic camptothecin analogues, and process for preparing them |
| 04/10/2002 | EP0752876B1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 04/10/2002 | EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344287A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344271A Remedies |
| 04/10/2002 | CN1344269A Pharmaceutical compsn. based on polyaromatic compounds |
| 04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
| 04/10/2002 | CN1344254A Quinoline derivatives and quinazoline derivatives |
| 04/10/2002 | CN1344167A Use of antibodies for anticancer vaccination |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344163A Stabilized oral pharmaceutical compsn. contg. iodide and iodate and method |
| 04/10/2002 | CN1344162A Medical compsns. |
| 04/10/2002 | CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 04/10/2002 | CN1344159A Combinations for treatment of diseases involving angiogenesis |